Literature DB >> 34633859

Metabolic and Signaling Roles of Ketone Bodies in Health and Disease.

Patrycja Puchalska1, Peter A Crawford1,2.   

Abstract

Ketone bodies play significant roles in organismal energy homeostasis, serving as oxidative fuels, modulators of redox potential, lipogenic precursors, and signals, primarily during states of low carbohydrate availability. Efforts to enhance wellness and ameliorate disease via nutritional, chronobiological, and pharmacological interventions have markedly intensified interest in ketone body metabolism. The two ketone body redox partners, acetoacetate and D-β-hydroxybutyrate, serve distinct metabolic and signaling roles in biological systems. We discuss the pleiotropic roles played by both of these ketones in health and disease. While enthusiasm is warranted, prudent procession through therapeutic applications of ketogenic and ketone therapies is also advised, as a range of metabolic and signaling consequences continue to emerge. Organ-specific and cell-type-specific effects of ketone bodies are important to consider as prospective therapeutic and wellness applications increase.

Entities:  

Keywords:  ketones and SGLT inhibitors; ketones and cancer; ketones and fatty liver disease; ketones and heart failure; ketones and neurodegenerative disease; ketones and the gut

Mesh:

Substances:

Year:  2021        PMID: 34633859      PMCID: PMC8922216          DOI: 10.1146/annurev-nutr-111120-111518

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   9.323


  196 in total

1.  Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.

Authors:  Christian Wolfrum; Esra Asilmaz; Edlira Luca; Jeffrey M Friedman; Markus Stoffel
Journal:  Nature       Date:  2004-12-23       Impact factor: 49.962

2.  Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.

Authors:  Matthieu Ruiz; François Labarthe; Annik Fortier; Bertrand Bouchard; Julie Thompson Legault; Virginie Bolduc; Odile Rigal; Jane Chen; Anique Ducharme; Peter A Crawford; Jean-Claude Tardif; Christine Des Rosiers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-14       Impact factor: 4.733

3.  Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.

Authors:  Justin A Fletcher; Stanisław Deja; Santhosh Satapati; Xiaorong Fu; Shawn C Burgess; Jeffrey D Browning
Journal:  JCI Insight       Date:  2019-04-23

Review 4.  Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  Cell Metab       Date:  2017-08-31       Impact factor: 27.287

5.  Gut Microbiota-Induced Changes in β-Hydroxybutyrate Metabolism Are Linked to Altered Sociability and Depression in Alcohol Use Disorder.

Authors:  Sophie Leclercq; Tiphaine Le Roy; Sonia Furgiuele; Valentin Coste; Laure B Bindels; Quentin Leyrolle; Audrey M Neyrinck; Caroline Quoilin; Camille Amadieu; Géraldine Petit; Laurence Dricot; Vanessa Tagliatti; Patrice D Cani; Kristin Verbeke; Jean-Marie Colet; Peter Stärkel; Philippe de Timary; Nathalie M Delzenne
Journal:  Cell Rep       Date:  2020-10-13       Impact factor: 9.423

6.  Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.

Authors:  Kenneth C Bedi; Nathaniel W Snyder; Jeffrey Brandimarto; Moez Aziz; Clementina Mesaros; Andrew J Worth; Linda L Wang; Ali Javaheri; Ian A Blair; Kenneth B Margulies; J Eduardo Rame
Journal:  Circulation       Date:  2016-01-27       Impact factor: 29.690

7.  Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via β-hydroxybutyrate.

Authors:  Chun-Kai Huang; Po-Hao Chang; Wen-Hung Kuo; Chi-Long Chen; Yung-Ming Jeng; King-Jen Chang; Jin-Yuh Shew; Chun-Mei Hu; Wen-Hwa Lee
Journal:  Nat Commun       Date:  2017-03-10       Impact factor: 14.919

8.  Suppression of insulin feedback enhances the efficacy of PI3K inhibitors.

Authors:  Benjamin D Hopkins; Chantal Pauli; Xing Du; Diana G Wang; Xiang Li; David Wu; Solomon C Amadiume; Marcus D Goncalves; Cindy Hodakoski; Mark R Lundquist; Rohan Bareja; Yan Ma; Emily M Harris; Andrea Sboner; Himisha Beltran; Mark A Rubin; Siddhartha Mukherjee; Lewis C Cantley
Journal:  Nature       Date:  2018-07-04       Impact factor: 49.962

9.  Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depression.

Authors:  Naofumi Kajitani; Masaaki Iwata; Akihiko Miura; Kyohei Tsunetomi; Takehiko Yamanashi; Ryoichi Matsuo; Tsuyoshi Nishiguchi; Saki Fukuda; Mayu Nagata; Midori Shibushita; Takahira Yamauchi; Shenghong Pu; Yukihiko Shirayama; Ken Watanabe; Koichi Kaneko
Journal:  Neuropsychopharmacol Rep       Date:  2020-03-03

10.  The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense.

Authors:  Julie L Horton; Michael T Davidson; Clara Kurishima; Rick B Vega; Jeffery C Powers; Timothy R Matsuura; Christopher Petucci; E Douglas Lewandowski; Peter A Crawford; Deborah M Muoio; Fabio A Recchia; Daniel P Kelly
Journal:  JCI Insight       Date:  2019-02-21
View more
  7 in total

Review 1.  Exogenous Ketone Supplements in Athletic Contexts: Past, Present, and Future.

Authors:  Mark Evans; Tyler S McClure; Andrew P Koutnik; Brendan Egan
Journal:  Sports Med       Date:  2022-10-10       Impact factor: 11.928

2.  Detecting de novo Hepatic Ketogenesis Using Hyperpolarized [2-13C] Pyruvate.

Authors:  Mukundan Ragavan; Marc A McLeod; Anna Rushin; Matthew E Merritt
Journal:  Front Physiol       Date:  2022-02-07       Impact factor: 4.566

3.  Ketone body oxidation increases cardiac endothelial cell proliferation.

Authors:  Eva-Maria Weis; Patrycja Puchalska; Alisa B Nelson; Jacqueline Taylor; Iris Moll; Sana S Hasan; Matthias Dewenter; Marco Hagenmüller; Thomas Fleming; Gernot Poschet; Agnes Hotz-Wagenblatt; Johannes Backs; Peter A Crawford; Andreas Fischer
Journal:  EMBO Mol Med       Date:  2022-02-18       Impact factor: 14.260

4.  Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis.

Authors:  Shaza Asif; Ri Youn Kim; Thet Fatica; Jordan Sim; Xiaoling Zhao; Yena Oh; Alix Denoncourt; Angela C Cheung; Michael Downey; Erin E Mulvihill; Kyoung-Han Kim
Journal:  Mol Metab       Date:  2022-04-12       Impact factor: 8.568

5.  Metabolomic profiling of samples from pediatric patients with asthma unveils deficient nutrients in African Americans.

Authors:  Hui-Qi Qu; Joseph Glessner; Jingchun Qu; Steven Gilhool; Frank Mentch; Ian Campbell; Patrick Sleiman; John J Connolly; Hakon Hakonarson
Journal:  iScience       Date:  2022-06-22

6.  Ketogenic diet uncovers differential metabolic plasticity of brain cells.

Authors:  Tim Düking; Lena Spieth; Stefan A Berghoff; Lars Piepkorn; Annika M Schmidke; Miso Mitkovski; Nirmal Kannaiyan; Leon Hosang; Patricia Scholz; Ali H Shaib; Lennart V Schneider; Dörte Hesse; Torben Ruhwedel; Ting Sun; Lisa Linhoff; Andrea Trevisiol; Susanne Köhler; Adrian Marti Pastor; Thomas Misgeld; Michael Sereda; Imam Hassouna; Moritz J Rossner; Francesca Odoardi; Till Ischebeck; Livia de Hoz; Johannes Hirrlinger; Olaf Jahn; Gesine Saher
Journal:  Sci Adv       Date:  2022-09-16       Impact factor: 14.957

Review 7.  Function and mechanism of histone β-hydroxybutyrylation in health and disease.

Authors:  Tingting Zhou; Xi Cheng; Yanqiu He; Yumei Xie; Fangyuan Xu; Yong Xu; Wei Huang
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.